These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition. Zhang Y; Zhou XH; Meranus DH; Wang L; Kukull WA Alzheimer Dis Assoc Disord; 2016; 30(2):113-7. PubMed ID: 26067923 [TBL] [Abstract][Full Text] [Related]
28. Moderating risk of Alzheimer's disease through the use of anxiolytic agents. Burke SL; O'Driscoll J; Alcide A; Li T Int J Geriatr Psychiatry; 2017 Dec; 32(12):1312-1321. PubMed ID: 27805724 [TBL] [Abstract][Full Text] [Related]
29. Role of nurses in addressing modifiable risk factors for early Alzheimer's disease and mild cognitive impairment. Hope K Br J Nurs; 2020 Apr; 29(8):460-469. PubMed ID: 32324452 [TBL] [Abstract][Full Text] [Related]
30. Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis. Imfeld P; Bodmer M; Jick SS; Meier CR Drug Saf; 2015 Oct; 38(10):909-19. PubMed ID: 26123874 [TBL] [Abstract][Full Text] [Related]
31. Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes. Ulstein I; Bøhmer T J Alzheimers Dis; 2017; 55(2):717-725. PubMed ID: 27716664 [TBL] [Abstract][Full Text] [Related]
32. A comparison of emotional decoding abilities in patients with amnestic mild cognitive impairment, very mild and mild Alzheimer's disease. Klimkowicz-Mrowiec A; Krzywoszanski L; Spisak K; Donohue BE; Szczudlik A; Slowik A Curr Alzheimer Res; 2014 Feb; 11(2):200-5. PubMed ID: 24359502 [TBL] [Abstract][Full Text] [Related]
33. Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment. Wilcockson TDW; Mardanbegi D; Xia B; Taylor S; Sawyer P; Gellersen HW; Leroi I; Killick R; Crawford TJ Aging (Albany NY); 2019 Aug; 11(15):5389-5398. PubMed ID: 31375642 [TBL] [Abstract][Full Text] [Related]
37. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease. Nogueira J; Freitas S; Duro D; Almeida J; Santana I Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598 [TBL] [Abstract][Full Text] [Related]
38. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415 [TBL] [Abstract][Full Text] [Related]
39. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients. Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973 [TBL] [Abstract][Full Text] [Related]